These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 27131971

  • 1. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
    Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P.
    J Transl Med; 2016 May 01; 14(1):99. PubMed ID: 27131971
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
    Esposito M, Ruffini F, Bellone M, Gagliani N, Battaglia M, Martino G, Furlan R.
    J Neuroimmunol; 2010 Mar 30; 220(1-2):52-63. PubMed ID: 20149931
    [Abstract] [Full Text] [Related]

  • 4. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N.
    Clin Immunol Immunopathol; 1996 Sep 30; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
    McDonald CA, Payne NL, Sun G, Moussa L, Siatskas C, Lim R, Wallace EM, Jenkin G, Bernard CC.
    J Neuroinflammation; 2015 Jun 03; 12():112. PubMed ID: 26036872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c+CD11b+Gr1+ myeloid-derived dendritic cells.
    Kaushansky N, Kaminitz A, Allouche-Arnon H, Ben-Nun A.
    J Neuroimmunol; 2019 Aug 15; 333():476953. PubMed ID: 31108399
    [Abstract] [Full Text] [Related]

  • 8. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glatiramer Acetate: from Bench to Bed and Back.
    Arnon R, Aharoni R.
    Isr Med Assoc J; 2019 Mar 01; 21(3):151-157. PubMed ID: 30905097
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human amniotic epithelial cells suppress relapse of corticosteroid-remitted experimental autoimmune disease.
    Liu YH, Chan J, Vaghjiani V, Murthi P, Manuelpillai U, Toh BH.
    Cytotherapy; 2014 Apr 01; 16(4):535-44. PubMed ID: 24411589
    [Abstract] [Full Text] [Related]

  • 13. Glatiramer acetate-specific antibody titres in patients with relapsing / remitting multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Bomprezzi R, Schaefer R, Reese V, Misra A, Vollmer TL, Kala M.
    Scand J Immunol; 2011 Sep 01; 74(3):219-226. PubMed ID: 21615449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
    Taylor AW, Kitaichi N.
    Brain Behav Immun; 2008 Jul 01; 22(5):639-46. PubMed ID: 18171609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.
    Ann N Y Acad Sci; 2004 Dec 01; 1029():239-49. PubMed ID: 15681762
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
    Tsunoda I, Kuang LQ, Igenge IZ, Fujinami RS.
    J Neuroimmunol; 2005 Mar 01; 160(1-2):122-34. PubMed ID: 15710465
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.